Shin Nippon Biomedical Laboratories Ltd. logo

Shin Nippon Biomedical Laboratories Ltd. (YB3)

Market Closed
10 Aug, 20:00
XSTU XSTU
7. 95
-0.1
-1.2422%
48.21B Market Cap
- P/E Ratio
50% Div Yield
340 Volume
- Eps
8.05
Previous Close
Add Transaction
Day Range
7.95 8.2
Year Range
5.7 10.6
Want to track YB3 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

YB3 closed today lower at €7.95, a decrease of -1.2422% from yesterday's close, completing a monthly increase of 29.2683% or €1.8. Over the past 12 months, YB3 stock lost -11.6667%.
YB3 pays dividends to its shareholders, with the most recent payment made on Dec 01, 2025. The next announced payment will be in In 1 month on Sep 29, 2026 for a total of €20.
The last earnings report, released on Aug 03, 2025, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
Shin Nippon Biomedical Laboratories Ltd. has completed 1 stock splits, with the recent split occurring on Sep 27, 2005.
The company's stock is traded on 6 different exchanges and in various currencies, with the primary listing on JPX (JPY).

YB3 Chart

Shin Nippon Biomedical Laboratories Ltd. (YB3) FAQ

What is the stock price today?

The current price is €7.95.

On which exchange is it traded?

Shin Nippon Biomedical Laboratories Ltd. is listed on XSTU.

What is its stock symbol?

The ticker symbol is YB3.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 50%.

What is its market cap?

As of today, the market cap is 48.21B.

Has Shin Nippon Biomedical Laboratories Ltd. ever had a stock split?

Shin Nippon Biomedical Laboratories Ltd. had 1 splits and the recent split was on Sep 27, 2005.

Shin Nippon Biomedical Laboratories Ltd. Profile

Professional Services Industry
Industrials Sector
Dr. Ryoichi Nagata F.F.P.M., M.D., Ph.D. CEO
XSTU Exchange
JP3379950003 ISIN
Japan Country
1,531 Employees
29 Sep 2026 Last Dividend
27 Sep 2005 Last Split
- IPO Date

Overview

Shin Nippon Biomedical Laboratories, Ltd., established in 1957 and based in Kagoshima, Japan, operates as a comprehensive contract research organization (CRO) with a global footprint. The company specializes in a myriad of services ranging from non-clinical to clinical research stages, contributing significantly to the pharmaceutical and biotech sectors. Its operations are diverse, offering in-depth studies and support services in the development of pharmaceuticals and therapeutics, alongside engaging in renewable energy generation, hospitality, and wellbeing sectors — illustrating a versatile business model that extends beyond biomedical research.

Products and Services

  • Non-Clinical Studies - Comprehensive suite of studies including toxicity, genotoxicity, carcinogenicity, pharmacokinetics, and others, essential for early-stage drug development.
  • Clinical Trial Support Services - Assistance in clinical trial protocols, investigator brochures, investigational drug allocation, and more, facilitating the smooth execution of trials.
  • Monitoring and Quality Management - Overseeing clinical trials to ensure compliance with regulatory standards and protocol adherence, ensuring data integrity and trial accuracy.
  • Data Management and Statistical Analysis - Handling the vast datasets collected during trials, and applying statistical methods to analyze the results, contributing to evidence-based conclusions.
  • Regulatory Affairs Consulting - Expert advisory services on regulatory strategies and submissions, helping to navigate complex regulatory landscapes.
  • Translational Research Services - Supports the continuum from laboratory research to clinical application, specializing in vaccines, therapeutic drugs, and various biotechnological medicines.
  • Site Management Organization Services - Facilitating the administrative and operational aspects of clinical trial sites, ensuring efficient trial execution.
  • Geothermal Power Generation - Operation of renewable energy facilities, showcasing the company’s commitment to sustainable practices.
  • Hotel Accommodation Facilities - Management of hospitality services, providing accommodation and related services.
  • Wellbeing Businesses - Offering cleaning, clerical, and welfare services, further diversifying its business portfolio outside of the biomedical field.

Contact Information

Address: 2438 Miyanoura-cho
Phone: 81 9 9294 2600